Plants for delivery of edible vaccines

Amanda M. Walmsley, Charles J. Arntzen

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.

Original languageEnglish (US)
Pages (from-to)126-129
Number of pages4
JournalCurrent Opinion in Biotechnology
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2000
Externally publishedYes

Fingerprint

Edible Vaccines
Vaccines
Animals
Immunology
Animal Diseases
Molecular biology
Plant Development
Immune system
Antigens
Allergy and Immunology
Crops
Molecular Biology
Immune System
Vaccination
Clinical Trials
Proteins
Research

ASJC Scopus subject areas

  • Biotechnology

Cite this

Plants for delivery of edible vaccines. / Walmsley, Amanda M.; Arntzen, Charles J.

In: Current Opinion in Biotechnology, Vol. 11, No. 2, 01.04.2000, p. 126-129.

Research output: Contribution to journalArticle

Walmsley, Amanda M. ; Arntzen, Charles J. / Plants for delivery of edible vaccines. In: Current Opinion in Biotechnology. 2000 ; Vol. 11, No. 2. pp. 126-129.
@article{f0a735b7213b4099b9f6fbd3298e98c2,
title = "Plants for delivery of edible vaccines",
abstract = "Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.",
author = "Walmsley, {Amanda M.} and Arntzen, {Charles J.}",
year = "2000",
month = "4",
day = "1",
doi = "10.1016/S0958-1669(00)00070-7",
language = "English (US)",
volume = "11",
pages = "126--129",
journal = "Current Opinion in Biotechnology",
issn = "0958-1669",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Plants for delivery of edible vaccines

AU - Walmsley, Amanda M.

AU - Arntzen, Charles J.

PY - 2000/4/1

Y1 - 2000/4/1

N2 - Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.

AB - Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.

UR - http://www.scopus.com/inward/record.url?scp=0034026208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034026208&partnerID=8YFLogxK

U2 - 10.1016/S0958-1669(00)00070-7

DO - 10.1016/S0958-1669(00)00070-7

M3 - Article

C2 - 10753769

AN - SCOPUS:0034026208

VL - 11

SP - 126

EP - 129

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

IS - 2

ER -